Jane Street’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-95,380
Closed -$103K 11434
2022
Q1
$103K Buy
95,380
+67,529
+242% +$51K ﹤0.01% 9445
2021
Q4
$20K Buy
+27,851
New +$22.5K ﹤0.01% 9803
2021
Q3
Sell
-34,418
Closed -$57K 11125
2021
Q2
$57K Buy
+34,418
New +$57.5K ﹤0.01% 9478
2020
Q2
Sell
-24,169
Closed -$19K 7736
2020
Q1
$19K Buy
+24,169
New +$25.6K ﹤0.01% 5182
2019
Q4
Sell
-24,612
Closed -$35K 5997
2019
Q3
$35K Buy
+24,612
New +$34.8K ﹤0.01% 4922
2018
Q4
Sell
-34,705
Closed -$64K 5997
2018
Q3
$64K Buy
+34,705
New +$67.3K ﹤0.01% 4905
2014
Q3
Sell
-19,398
Closed -$225K 3222
2014
Q2
$225K Buy
+19,398
New +$220K ﹤0.01% 2099
2013
Q4
Sell
-14,790
Closed -$249K 3045
2013
Q3
$249K Buy
+14,790
New +$208K ﹤0.01% 2243

Other funds holding MBII

Jane Street's MBII Position: Q2 2022 in Review

Jane Street sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 95,380 shares — an estimated $103K sold.

Jane Street first reported a position in MBII in Q3 2013 and held it in 8 quarters. The position peaked at $249K in Q3 2013. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Jane Street reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Jane Street sold 95,380 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $103K.
  • Jane Street first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 8 quarters.
  • Jane Street's Marrone Bio Innovations, Inc. position peaked at $249K in Q3 2013.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.